Single‐fraction prostate‐specific membrane antigen positron emission tomography‐ and multiparametric magnetic resonance imaging‐guided stereotactic body radiotherapy for prostate cancer local recurrences-Reference-Cited by-同舟云学术

Single‐fraction prostate‐specific membrane antigen positron emission tomography‐ and multiparametric magnetic resonance imaging‐guided stereotactic body radiotherapy for prostate cancer local recurrences

Published:2022-10-09 Issue:1 Volume:131 Page:101-108
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

Ehret Felix¹²³^ORCID,Hofmann Theresa³,Fürweger Christoph³⁴,Kufeld Markus³,Staehler Michael⁵,Muacevic Alexander³,Haidenberger Alfred³

Affiliation:

1. Berlin Institute of Health at Charité – Universitätsmedizin Berlin Berlin Germany

2. Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Department of Radiation Oncology Berlin Germany

3. European Radiosurgery Center Munich Munich Germany

4. Department of Stereotaxy and Functional Neurosurgery University Hospital Cologne Cologne Germany

5. Department of Urology Ludwig‐Maximilians‐University Munich Munich Germany

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15894

Reference30 articles.

1. Cancer Statistics, 2021

2. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options